Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Santen Pharmaceutical Co Ltd (OTC Pink - Current Information:SNPHY)

14.87
Delayed Data
As of Sep 01
 -0.67 / -4.28%
Today’s Change
10.57
Today|||52-Week Range
17.08
+39.08%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
Operating ActivitiesNet Income / Starting Line352.9M308.9M267.9M218.0M
 
 
 
 
 
Depreciation37.5M39.7M39.1M63.1M
 
 
 
 
 
Total Other Cash Flow-114.7M-144.4M-40.6M5.5M
 
 
 
 
 
Funds From Operations275.7M204.2M266.3M286.6M
 
 
 
 
 
Funds From/For Other Operating Expenses2.8M84.2M7.8M56.3M
 
 
 
 
 
Net Cash Flow - Operating Activities272.8M120.0M258.5M230.3M
 
 
 
 
 
 
InvestingIncrease In Investments-53.4M-68.6M-49.3M-1.8M
 
 
 
 
 
Decrease In Investments101.7M56.5M30.3M39.3M
 
 
 
 
 
Capital Expenditures-41.7M-43.5M-47.7M-27.0M
 
 
 
 
 
Fixed Asset Disposal76.2K446.6K109.6K5.9M
 
 
 
 
 
Net Assets From Acquisitions -137.2M0.000.000.00
 
 
Other Investing - Uses-88.9K-217.3K-69.7K-544.2K
 
 
 
 
 
Other Investing - Sources88.9K24.1K0.000.00
 
 
 
Net Cash Flow Investing-130.5M-55.5M-66.7M-559.7M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings0.000.000.00362.8M
 
 
Long Term Debt Reduction0.000.000.00-26.9M
 
 
Net Proceeds Stock Sale0.000.000.000.00--
Common Preferred Redeemed-25.4K-166.1M-59.8K0.00
 
 
 
 
Common Dividends-110.6M-102.2M-82.1M-75.0M
 
 
 
 
 
Cash Dividends Paid - Total-110.6M-102.2M-82.1M-75.0M
 
 
 
 
 
Other Sources - Financing1.9M8.1M3.0M1.8M
 
 
 
 
 
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing-108.7M-260.2M-79.2M262.7M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash-1.3M11.7M12.8M8.1M
 
 
 
 
 
 
Net Change In Cash33.7M-195.7M112.7M-66.8M